dc.contributor.author | Izgi, N | |
dc.contributor.author | Cobanoglu, Seçkin | |
dc.contributor.author | Unal, Fatih Erman | |
dc.contributor.author | Yanik, Burcu | |
dc.contributor.author | Kucuk, Mutlu | |
dc.contributor.author | Gorgulu, A | |
dc.contributor.author | Kins, T | |
dc.date.accessioned | 2021-03-03T20:40:30Z | |
dc.date.available | 2021-03-03T20:40:30Z | |
dc.date.issued | 2000 | |
dc.identifier.citation | Gorgulu A., Kins T., Cobanoglu S., Unal F. E. , Izgi N., Yanik B., Kucuk M., "Reduction of edema and infarction by memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat", ACTA NEUROCHIRURGICA, cilt.142, sa.11, ss.1287-1292, 2000 | |
dc.identifier.issn | 0001-6268 | |
dc.identifier.other | av_5b2b743d-8cf5-41fd-a739-e5f15bde5aeb | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/64016 | |
dc.identifier.uri | https://doi.org/10.1007/s007010070027 | |
dc.description.abstract | N-methyl-D-aspartate (NMDA) receptor antagonists have been found to be protective after cerebral ischemia. However most of these drugs have limited value as neuroprotectives in clinical therapy because of their side effects. Memantine is a noncompetitive NMDA receptor antagonist and it has been used for the treatment of various cerebral disorders with relatively few side effects. We investigated the beneficial effects of Memantine and compared its effect with MK-801 in a temporary focal cerebral ischemia model. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | CERRAHİ | |
dc.subject | Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Reduction of edema and infarction by memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat | |
dc.type | Makale | |
dc.relation.journal | ACTA NEUROCHIRURGICA | |
dc.contributor.department | Trakya Üniversitesi , , | |
dc.identifier.volume | 142 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 1287 | |
dc.identifier.endpage | 1292 | |
dc.contributor.firstauthorID | 5642 | |